Is fluorometric sentinel lymph node biopsy in endometrial cancer necessary?

被引:0
作者
Huang, Liqiong [1 ]
Cheng, Wei [2 ]
He, Chenghui [1 ]
Li, Xin [2 ]
Huang, Lu [2 ]
Zhang, Jiajia [2 ]
Song, Liwen [1 ]
Zhou, Yifan [1 ]
Wang, Chenchen [3 ]
Gan, Xiaoqin [2 ]
Qiu, Jin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Obstet & Gynecol, Sch Med, Shanghai, Peoples R China
[2] Univ Elect Sci & Technol China, Chengdu Womens & Childrens Cent Hosp, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China
[3] Shanghai United Family Pudong Hosp, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
endometrial cancer; SLNB; case-control study; prognosis; surgery; LYMPHADENECTOMY; METASTASIS;
D O I
10.3389/fmed.2024.1434311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective In this study, we collected perioperative and postoperative follow-up data from patients with endometrial cancer (EC) at different stages to evaluate the role of sentinel lymph node biopsy (SLNB) in endometrial cancer surgery.Methods A total of 186 endometrial cancer patients undergoing radical hysterectomy from January 2018 to April 2022 were retrospectively analyzed. Patients were classified into four groups. Group A comprised patients diagnosed with stage IA grade 1 and 2 endometrioid EC who underwent SLNB. Group B comprised patients with stage IA grade 1 and 2 endometrioid EC who did not undergo SLNB. Group C comprised patients with higher-grade endometrioid EC, wherein systematic lymph node dissection was performed based on SLNB results. Group D comprised patients with higher-grade endometrioid EC who did not undergo SLNB and instead underwent direct systematic lymph node dissection. Clinical, pathological data, and follow-up information for all patients were collected.Results In Group A and B, SLNB was performed on 36 out of 67 patients with IA stage 1 and 2 endometrial cancer, yielding a SLN positivity rate of 5.6%. There were no significant differences observed between the two groups regarding perioperative outcomes and postoperative follow-up. Conversely, among 119 patients with higher-grade endometrial cancer, 52 underwent SLNB, with 20 patients exhibiting SLN positivity, resulting in a SLN positivity rate of 38.4%. However, the decision to undergo SLNB did not yield significant differences in perioperative outcomes and postoperative follow-up among these patients.Conclusion For stage IA grade 1 and 2 endometrioid EC, the incidence of lymph node positivity is low, omitting SLNB in this subpopulation is a feasible option. In other stages of endometrioid EC, there is no significant difference in perioperative and postoperative follow-up data between patients undergoing routine systematic lymphadenectomy and those undergoing systematic lymphadenectomy based on SLNB results. Therefore, if SLNB is not available, the standard procedure of PLND remains an option to obtain information about lymph node status, despite the surgical complications associated with this procedure.
引用
收藏
页数:8
相关论文
共 43 条
[1]   In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer [J].
Aboulouard, Soulaimane ;
Wisztorski, Maxence ;
Duhamel, Marie ;
Saudemont, Philippe ;
Cardon, Tristan ;
Narducci, Fabrice ;
Lemaire, Anne-Sophie ;
Kobeissy, Firas ;
Leblanc, Eric ;
Fournier, Isabelle ;
Salzet, Michel .
CELL REPORTS MEDICINE, 2021, 2 (06)
[2]   Robotic sentinel lymph node mapping with sensitive Firefly for endometrial cancer staging [J].
Anastasio, Mary Katherine ;
Darling, Alice ;
Rossi, Emma C. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (07) :1105-1106
[3]   Sentinel lymph node intraoperative analysis in endometrial cancer [J].
Bellaminutti, Serena ;
Bonollo, Marta ;
Gasparri, Maria Luisa ;
Clivio, Luca ;
Migliora, Paola ;
Mazzucchelli, Luca ;
Papadia, Andrea .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (12) :3199-3205
[4]   FIGO staging of endometrial cancer: 2023 [J].
Berek, Jonathan ;
Matias-Guiu, Xavier ;
Creutzberg, Carien ;
Fotopoulou, Christina ;
Gaffney, David ;
Kehoe, Sean ;
Lindemann, Kristina ;
Mutch, David ;
Concin, Nicole ;
Endometrial Canc Staging Subcomm ;
FIGO Womens Canc Comm .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 162 (02) :383-394
[5]   Uterine fundus indocyanine green injection for sentinel lymph node biopsy in endometrial cancer patients with limited access to cervical injection [J].
Bizzarri, Nicolo ;
Parisi, Giuseppe ;
Di Berardino, Stefano ;
Naccarato, Laura ;
Scambia, Giovanni ;
Fanfani, Francesco .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (06) :952-953
[6]   Peritoneal mesometrial resection with lymphadenectomy following prior hysterectomy in intermediate/high-risk endometrial cancer: feasibility and safety [J].
Buderath, Paul ;
Elgharib, Mohamed ;
Kimmig, Rainer .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 309 (04) :1569-1574
[7]   Endometrial cancer: A review and current management strategies: Part I [J].
Burke, William M. ;
Orr, James ;
Leitao, Mario ;
Salom, Emery ;
Gehrig, Paola ;
Olawaiye, Alexander B. ;
Brewer, Molly ;
Boruta, Dave ;
Villella, Jeanine ;
Herzog, Tom ;
Abu Shahin, Fadi .
GYNECOLOGIC ONCOLOGY, 2014, 134 (02) :385-392
[8]  
Burke WM, 2014, GYNECOL ONCOL, V134, P393, DOI 10.1016/j.ygyno.2014.06.003
[9]   ASO Author Reflections: National Implementation of Sentinel Lymph Node Biopsy in Early-Stage Endometrial Cancer [J].
Cabrera, S. ;
Spain GOG .
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) :7665-7666
[10]   Let go of the myth: safety of indocyanine green for sentinel lymph node mapping in endometrial cancer [J].
Capasso, Ilaria ;
Cucinella, Giuseppe ;
Volcheck, Gerald ;
Mcgree, Michaela ;
Fought, Angela J. ;
Chuzhyk, Olena ;
De Vitis, Luigi Antonio ;
Schivardi, Gabriella ;
Fumagalli, Diletta ;
Occhiali, Tommaso ;
Fanfani, Francesco ;
Chiantera, Vito ;
Scambia, Giovanni ;
Reynolds, Evelyn ;
Mariani, Andrea ;
Glaser, Gretchen .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (01) :80-87